Professional Documents
Culture Documents
Accepted Article
Running title: BTA in lip augmentation
Yunzhu Li1 MD, Yuming Chong2 MD, Nanze Yu1 MD, Ruijia Dong2 MD, Xiao Long1* MD
1Department of Plastic Surgery, Peking Union Medical College (PUMC) Hospital, PUMC and
Xiao Long
Email: pumclongxiao@126.com
Address: Peking Union Medical College Hospital, No.1, Shuaifuyuan, Dongcheng District,
Beijing, China
ACKNOWLEGEMENT
This article has been accepted for publication and undergone full peer review but has not been
through the copyediting, typesetting, pagination and proofreading process, which may lead to
differences between this version and the Version of Record. Please cite this article as doi:
10.1111/JOCD.13731
This article is protected by copyright. All rights reserved
Accepted Article
DR. YUNZHU LI (Orcid ID : 0000-0003-1667-7908)
ABSTRACT
Background: Full lips are beauty standards. Botulinum toxin A (BTA) paralyzes the
orbicularis oris muscle to achieve the eversion of the lip, and thus makes the lip look plump.
Objectives: This study presents three cases of BTA injection to the lip and evaluates the
possible changes of the labial morphology and the lip surface area.
Methods: Three patients received a total of 4U BTA injection at the vermilion border of the
upper lip. Vectra® H1 3D imaging system was used to capture 3D photographs of the lips
before injection and two weeks after injection. Eight linear distances and the upper lip surface
area were measured. Anthropometric measurements before and after injection were
compared.
Results: Patients displayed a larger upper vermillion height (p=0.038) and a smaller
cutaneous upper lip height (p=0.024). There was a trend for a larger upper lip surface area,
but not statistically significant (p=0.109). Symptoms of slight perioral muscular palsy and
Conclusion: BTA helps to enlarge the upper lip and shorten the philtrum. The BTA injection
A plump lip is the symbol of youth and glamorousness. Influenced by sun damage, genetic
factors, and smoking, aging will cause volume loss and perioral wrinkles to the lip1. Lip
augmentation with dermal filler is frequently performed to offset the age-related changes and
polypeptide chain molecule derived from the Clostridum botulinum bacterium. By blocking
the release of acetylcholine at the myoneural junction, BTA inhibits the contraction of
orbicularis oris muscle and improves perioral wrinkles3. The paralyzed effect that BTA has
on the orbicularis oris muscle results in the eversion of the lips and achieves an augmented
outcome4. This study presents three cases of BTA injection to the lip and evaluates the
Case report
Three individuals (two females and one male) with no previous BTA treatment, with a mean
age of 28.7±5.5 received a total of 4U BTA (BOTOX®, Allergan; 40 U/mL) with 1 unit at
each site. The injection sites were located symmetrically at the vermilion border of the upper
lip at the dermis level (Figure 1). Vectra® H1 3D imaging system (Vectra M3, Canfield
Scientific Inc, USA) was used to capture 3D photographs of the patients with mouth gently
closed in a neutral expression before injection and two weeks after injection. Images were
then imported into the Canfield Mirror® imaging software. Nasolabial landmarks used in this
study were manually identified onto the 3D photographs (Figure 2). Eight linear distances
and the upper lip surface area were measured (Figure 3). The same author did all
measurements for two times with a two-week interval. The intra-class correlation coefficient
(ICC) was adopted to evaluate the intra-observer reliability. ICC value above 0.75 was
considered excellent reliability. Paired samples t-tests or Wilcoxon tests were carried out
according to the data normality to evaluate differences in labial morphology. Data were
processed using the Statistical Package for Social Sciences (SPSS®, version 23.0, MAC®).
intra-observer reliability (Table 1). The mean difference of all linear measurements did not
exceed 1 mm, indicating high precision. Patients displayed higher value of upper vermillion
height (p=0.038) and lower value of cutaneous upper lip height (p=0.024). The cupid’s bow
height was reduced (p=0.047), while the right vermillion margin lateral height increased
(p=0.034). There were trends for larger vermillion margin lateral height and larger upper lip
surface area but were not statistically significant (p=0.149 and p=0.109, respectively) (Table
2, Figure 4).
Notably, all three patients complaint about slight perioral muscular palsy and mouth
incompetence. One especially felt unable to hold the water in her mouth when drinking and
gargling. No facial asymmetry or drooling was reported. The symptoms together with the
Informed consent was obtained from the patient to present the case and images.
Discussion
Although aesthetic standards differ among different ethnicities and cultures, the
universally recognized beauty of the lip is a proportionally larger upper lip with more
protruding projection and a shorter philtrum5,6. Lip augmentation with hyaluronic acid,
silicone, or fat graft restores the lip fullness. Lip lift shortens the philtrum and increases the
exposure of dry red lip. However, severe complications such as vascular embolism and
hypertrophic scar hinder the operative effect 7,8. As a more minimally invasive treatment,
Orbicularis oris muscle is a circular muscle that lies around the lip and is the target of
BTA injection. It is composed of deep and superficial fiber with multiple functions. The deep
fiber is a constrictor muscle that helps to hold food and water when eating, while the
superficial fiber is a retractor muscle that works together with other muscles in speech and
facial expressions9. As is confirmed in the study, once the constricting function is restrained
by BTA, the lip becomes more everted and thus, a larger upper lip and a shorter philtrum are
lip-lift-alike effect that BTA injection has on the lip. While the lip-lift-alike effect is achieved,
the lip is flattened with reduced cupid’s bow height. Yin’s study found that, instead of the
accumulation of soft tissues, the philtrum ridge is formed by muscle strength around the lip10.
We believe BTA disrupts the original tension lines of the upper lip and as a result, flattens the
cupid’s bow. But on the whole, the therapeutic effects conform to the aesthetic trend of the
lip and thus, the BTA injection can be an option for lip enhancement. But because of the
rather small amount of BTA that we injected, the effects lasted fewer than a month. Further
investigation is needed to the evaluate the relationship between the injection dose and the
effect duration.
However, the same as our finding, BTA achieves lip augmentation while interferes with
the regular functions of the lip. It should be avoided among those patients with high oral
function requirements, such as singers and wind instrument musicians. In addition, the lip
might be flattened slightly since the cupid’ s bow height is reduced, which should be
Acknowledgement
References
1 Paes EC, Teepen HJLJM, Koop WA, et al.Perioral Wrinkles: Histologic Differences
Surgery.2015.8:139.
forensic odonto-stomatology.2019.2:25-34.
7 Ghannam S, Sattler S, Frank K, et al.Treating the Lips and Its Anatomical Correlate
8 Weston GW, Poindexter BD, Sigal RK, et al.Lifting lips: 28 years of experience using
J.2009.29:83-86.
9 Nicolau PJ.The orbicularis oris muscle: a functional approach to its repair in the cleft
Surg.2014.25:48-54.
Figure 1. Four injection sites. The injection sites were located symmetrically at the
vermilion border of the upper lips at the dermis level (shown in black dots).
labiale superius (ls); stomion (sto). Bilateral landmarks designated (R) for right and (L) for
left: crista philtri (cph); chelion (ch); the midpoint of vermillion margin (mvm).
Figure 3. Diagram of the linear and area measurements of the lip; (A) PW: philtrum
width (cph-cph); ULH: upper lip height (sn-sto); CULH: cutaneous upper lip height (sn-ls);
UVH: upper vermilion height (ls-st); CBH: cupid’s bow height (cph-ls); RVMLH: right
vermilion margin lateral height (mvmR-sto); LVMLH: left vermilion margin lateral height
(mvmL-sto). (B)The surface area of the upper lip (shown in dotted lines).
Figure 4. Photographs of a patient receiving a total of 4 U BTA at the upper lip; (A)
The mean difference of upper lip surface area is recorded in mm2, while the mean differences of other
Upper lip height 22.03 22.09 19.58 20.30 20.10 21.04 0.162
Upper cutaneous lip height 15.06 13.95 13.65 12.91 13.94 12.63 0.024
Upper vermillion height 6.97 8.13 5.93 7.39 6.15 8.41 0.038
Cupid’s bow height 2.00 1.16 1.52 0.91 1.83 1.46 0.047
Vermilion margin lateral height (right) 3.45 4.53 2.57 4.00 3.62 4.34 0.034
Vermilion margin lateral height (left) 4.55 4.95 2.42 4.31 4.41 5.19 0.149
Upper lip surface area 437 485 291 356 419 483 0.109
Upper lip surface area is recorded in mm2 and other parameters in mm.
jocd_13731_f1.jpg
jocd_13731_f2.jpg
jocd_13731_f3.jpg